Press "Enter" to skip to content

Novartis ‘completely committed’ to Sandoz, has no split-off plan

Earlier, Swiss newspaper Tages-Anzeiger reported the Basel-based drugmaker was preparing to split off Sandoz, citing an employee representative as well as participants in a Novartis investor event last week in London.

Original source:

Also Read:   Inspection of Unichem's Kolhapur facility by USFDA completed without observations